Status:
COMPLETED
Silicone vs Pirfenidone in the Treatment of Hypertrophic Scars and Keloids
Lead Sponsor:
Fundación Nacional para la Enseñanza y la Investigación de la Dermatología A.C.
Conditions:
Scars
Keloids
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Justification: Keloid scars are a major medical and cosmetic problem, especially in darker skin types that predominate in Mexico. It is estimated that hypertrophic scars affecting from 1.5 to 4.5% of...
Detailed Description
This is a comparative, non-inferiority, experimental, prospective, longitudinal pilot study with blind evaluator, in patients with keloid or hypertrophic scars. Twenty patients per group randomly assi...
Eligibility Criteria
Inclusion
- keloid or hypetrophic scar
Exclusion
- collagen diseases pregnancy previous treatment for 3 months
Key Trial Info
Start Date :
July 14 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 20 2016
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06909812
Start Date
July 14 2015
End Date
January 20 2016
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital General Manuel Gea González
Mexico City, Mexico City, Mexico, 01710